We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Pharmaceuticals.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Pharmaceuticals Product List and Ranking from 21 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Nov 05, 2025～Dec 02, 2025
This ranking is based on the number of page views on our site.

Pharmaceuticals Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Nov 05, 2025～Dec 02, 2025
This ranking is based on the number of page views on our site.

  1. メイプルバイオラボラトリーズ Chiba//Pharmaceuticals and Biotechnology
  2. マーケットリサーチセンター Tokyo//Service Industry
  3. 日本計画研究所 Tokyo//others
  4. 4 東レリサーチセンター Tokyo//Service Industry
  5. 5 大峰堂薬品工業 Nara//others
Go to Company Ranking

Pharmaceuticals Product ranking

Last Updated： Aggregation Period:Nov 05, 2025～Dec 02, 2025
This ranking is based on the number of page views on our site.

  1. Contract research and development for pharmaceuticals, cosmetics, and food. メイプルバイオラボラトリーズ
  2. Omine-do Pharmaceutical Industry Co., Ltd. Business Introduction 大峰堂薬品工業
  3. Business Introduction of the Technical Information Association, Inc. TECHNICAL INFOMATION INSTITUTE CO.,LTD
  4. Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals 関東化学株式会社 バイオケミカル部
  5. 4 [Seminar] Latest Trends in Policies for Stable Supply of Generic Drugs and Corporate Collaboration 日本計画研究所

Pharmaceuticals Product List

16～30 item / All 44 items

Displayed results
Contract research and development for pharmaceuticals, cosmetics, and food.

Contract research and development for pharmaceuticals, cosmetics, and food.

Leave the development, manufacturing, quality control, and testing of pharmaceuticals, quasi-drugs, and cosmetics to us!

Maple Biolaboratories specializes in testing, research, and development using microorganisms, as well as product development utilizing microbial control. We also conduct contract testing for antiviral activity. 【Do you have any of these concerns?】 ■ It is difficult to hire full-time researchers. ■ There is resistance to purchasing non-versatile development and measurement equipment. ■ It is challenging to prepare to secure facilities for research and development. ■ I want to significantly reduce development costs. And more. *For more details, please download our catalog or feel free to contact us.

  • ⓪　メイプルバイオ　会社前景-入り口.jpg
  • Other Testing Contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals

Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals

Usable from product development to actual manufacturing! 'Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals'

We sell "manufacturing-only pharmaceuticals" that can be used from product development to actual manufacturing. We supply products under strict quality control, including additional conformity testing for international standards. When purchasing this product (manufacturing-only pharmaceuticals), a license and a confirmation document are required in accordance with the Pharmaceutical and Medical Device Act. For more details, please refer to the catalog below.

  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Seminar] Current Status of Stable Supply of Pharmaceuticals and Government Initiatives

[Seminar] Current Status of Stable Supply of Pharmaceuticals and Government Initiatives

Ministry of Health, Labour and Welfare - Promoting the reform of the industrial structure of generic pharmaceuticals and aiming to strengthen the supply chain.

Our company will hold a business seminar. 【Seminar Details】 ■ Date and Time: September 18, 2025 (Thursday) 16:30 - 18:30 (Doors open at 16:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Instructor: Ministry of Health, Labour and Welfare Medical Affairs Bureau, Medical Industry Promotion and Medical Information Planning Division Director of Pharmaceutical Industry and Venture Support Policy Office Mr. Daisuke Fujii *For more details, please refer to the PDF document or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Introduction to the Seranostics Business

Introduction to the Seranostics Business

We would like to introduce a project aimed at the integration of imaging diagnosis and treatment using radiopharmaceuticals!

Theranostics, which closely links treatment and diagnosis, is expected to contribute to personalized medicine and the effective use of healthcare costs. By developing therapeutic agents using radioisotopes (RI: radioactive isotopes) that emit alpha particles, a type of radiation, along with companion diagnostic agents, we aim to realize theranostics. We have completed the CRADLE building and established the "Theranostics Production Technology Center." By placing a dedicated department, we will achieve the early supply of alpha-emitting radionuclides from the CRADLE building, while further strengthening collaboration between the drug discovery laboratory located within the same facility and the Chiba factory, thereby accelerating the development of theranostics drug discovery. 【Functions of the facility】 ■ Production of 225Ac and PET radionuclides ■ Handling of 177Lu and 211At, among others ■ Production of investigational drugs ■ Production of research-use RIs *For more details, please refer to the PDF document or feel free to contact us.

  • Other contract manufacturing
  • Other contract services
  • Pharmaceutical intermediate manufacturing services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Features of Aptamers

Features of Aptamers

Fits the shape of proteins! Nucleic acid molecules that can inhibit or regulate.

We would like to introduce the features of the "aptamer" that we handle. Single-stranded nucleic acids form various three-dimensional structures according to their sequences. Utilizing this structural capability, these nucleic acid molecules can bind to target proteins and inhibit or regulate their functions. Please feel free to contact us when you need assistance. 【Features】 ■ Creates a three-dimensional structure that fits the shape of the protein for binding, known as "shape capture." *For more details, please refer to the PDF materials or feel free to contact us.

  • Pharmaceutical Intermediates

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Examples of Analytical Methods in Biologics/Antibody Pharmaceuticals Held on February 16

Examples of Analytical Methods in Biologics/Antibody Pharmaceuticals Held on February 16

Introduction to analytical methods used for quality control of antibody pharmaceuticals! Online seminar introduction.

We are pleased to announce that our company will be hosting the third installment of our webinar series titled "Case Studies of Analytical Methods in Biologics/Antibody Drugs." In light of the growing development of biopharmaceuticals, our company has been strengthening its biopharmaceutical development capabilities. During this time, we have received numerous analytical project requests from our customers. In this webinar, we will introduce analytical methods used for quality control, using antibody drugs as examples, based on the knowledge we have cultivated thus far. We sincerely look forward to your participation. 【Overview】 ■ Date and Time: February 16 (Thursday) 11:00 AM - 11:30 AM ■ Format: Online (Teams) ■ Participation: Free *For more details, please refer to the related links or feel free to contact us.

  • Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Reagents, scientific instruments, pharmaceuticals

Reagents, scientific instruments, pharmaceuticals

Leave it to us for products related to research and development, including bio, genome, nanotechnology, with a core focus on reagent sales.

Our company has been providing products such as reagents, clinical testing agents, industrial chemicals, and scientific instruments to contribute to various users, including academic research institutions, industrial sectors, and the medical field, as a comprehensive reagent dealer. As a support industry for research and development, we will respond to advancements in science and technology and technological innovation by providing the information our customers seek and promoting proposal-based sales. Please feel free to contact us with any requests. 【Business Areas】 ■ Bio ■ Chemical ■ Clinical Testing ■ Quality Control and Analysis *For more details, please download the PDF or feel free to contact us.

  • Other contract services
  • Clinical Development Systems

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Keywords: microRNA, viral defense mechanisms, cell death due to viral infection, siRNA, nucleic acid medicines

mRNA is RNA that contains information for protein synthesis, but there are also many non-coding RNAs in the cell that do not carry messages. We have been elucidating the mechanisms by which immune responses to RNA virus infections are regulated by small non-coding RNAs called microRNAs. Understanding this mechanism may contribute to the development of novel nucleic acid medicines. Additionally, while siRNA also suppresses the expression of mRNA, siRNA has a suppressive effect on a single gene, whereas microRNA acts on entire specific gene groups. Although there are currently no nucleic acid medicines utilizing microRNA, we are hopeful that if the mechanisms of their action in virus-infected cells are clarified, the potential for nucleic acid medicines will expand even further.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents

Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents

Which is advantageous for identification: antigen, CDR, cross-reactivity, or hybridoma?

★What constitutes a strong patent specification and claims when acquiring rights for antibody drugs? ★Along with essential practical knowledge, we will teach you claim techniques that your company may not know, incorporating exercises! 【Instructor】Akihiko Okuno, Representative Employee, SK Patent Firm, Patent Attorney 【Venue】Tekuno Kawasaki, 5th Floor, Room 5 Training 【Kanagawa, Musashi-Mizonokuchi Station】 【Date and Time】November 29, 2010 (Monday) 13:00–16:00 【Lecture ends at 16:00. 16:00-16:30: Free Time Q&A】

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Trends in the Generic Pharmaceutical Industry and Basic Knowledge of Patents and Patent Strategies

Trends in the Generic Pharmaceutical Industry and Basic Knowledge of Patents and Patent Strategies

★Utilizing patents as a means of differentiation for generic pharmaceuticals! ★What is your perspective on the invalidation trials conducted by generic pharmaceutical companies as a business strategy?

Speaker Mr. Ichiro Tasaka, Patent Attorney, Nagasawa Patent Office/Tokyo Marunouchi Law Office Target Audience: Engineers and researchers interested in generic development strategies, patent analysis methods, etc. Venue RYUKA Intellectual Property Hall, 22F Seminar Room [Tokyo, Shinjuku] 3-minute walk from "Shinjuku" Station on JR, Odakyu Odawara Line, Keio Line, and Tokyo Metro Marunouchi Line Date and Time November 21, 2011 (Monday) 13:30-16:30 Capacity: 30 people *Registration will close once full. Please apply early. Participation Fee [Early Bird Discount Price] 19,950 yen per person (including tax and textbook fee) *Limited to Tech-Zone members who apply by November 7. Membership registration is free. *After November 7, the [Regular Price] will be 23,100 yen per person (including tax and textbook fee).

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【Industry-Specific Utilization Methods】Pharmaceuticals

【Industry-Specific Utilization Methods】Pharmaceuticals

We are introducing the three key points of GDP and two transportation methods corresponding to GDP!

In the pharmaceutical industry, it has become necessary to respond to GDP (Good Distribution Practice), which expands to include storage and transportation in the distribution process, as a complement to the conventional GMP (Good Manufacturing Practice) standards for manufacturing and quality control. Emphasis is placed on ensuring quality throughout the distribution process, with particular importance placed on temperature control. It is required that proper temperature management is maintained from the time products leave the manufacturing facility until they reach the patient. Wacon will assist you in complying with GDP using refrigerated boxes. *For more detailed information, please refer to the related links. For further details, you can download the PDF or feel free to contact us.*

  • Food transport materials (cooling, heat retention, etc.)

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Web Seminar: Characterization of Antibody-Related Pharmaceuticals

Web Seminar: Characterization of Antibody-Related Pharmaceuticals

Toray Research Center × SciEx × Protein Metrics Jointly Hosted Web Seminar (Characterization of Antibody-Related Pharmaceuticals)

Analysis of the Characteristics of Antibody-Related Pharmaceuticals – Detailed Modification Analysis Including Charge Variants and Glycans Using LC-MS and icIEF-UV/MS – < Event Overview > Date and Time: January 16, 2025 (Thursday) 15:00 - 16:00 Format: Online (Zoom) 1. Analysis of Charge Heterogeneity of Antibody-Related Pharmaceuticals Using the Intabio ZT System (Ryo Yokoyama, AB Sciex Co., Ltd.) 2. Case Studies of Characteristic Analysis of Biopharmaceuticals Using Mass Spectrometry (Satoko Ota, Toray Research Center, Inc.) 3. Improving Work Efficiency in Protein Pharmaceutical Analysis Using MS Data Analysis Software Byos (Ayako Kurimoto, Protein Metrics) ◆ Detailed Page for This Webinar https://proteinmetrics.com/%e6%8a%97%e4%bd%93%e9%96%a2%e9%80%a3%e5%8c%bb%e8%96%ac%e5%93%81%e3%81%ae%e7%89%b9%e6%80%a7%e8%a7%a3%e6%9e%90/

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Service Example] Major Pharmaceutical Company J

[Service Example] Major Pharmaceutical Company J

We will introduce examples of providing extensive support for the preparation of materials for internal controls and lectures for stakeholders, as well as support for the internal implementation of new business launches!

We would like to introduce a case where comprehensive project management was implemented for Company J, a major pharmaceutical company, while considering the legal regulations surrounding pharmaceutical sales. The company was exploring the launch of a new e-commerce platform in order to broaden its user base and achieve further sales growth. After the service was introduced, the synchronization of member information registered on the existing site with the e-commerce system was addressed, allowing purchasing behavior on the e-commerce platform to be reflected in the existing customer database in real-time. We provided extensive support for necessary e-commerce operations both before and after the release. [Challenges] - The company was exploring the launch of a new e-commerce platform to broaden its user base and achieve further sales growth. - There were several concerns regarding the construction of the e-commerce platform, including the specific regulations of the Pharmaceutical and Medical Device Act (formerly the Pharmaceutical Affairs Law) related to pharmaceutical e-commerce and the integration of member information registered on the existing site. *For more details, please refer to the related links or feel free to contact us.*

  • Internal Control and Operational Management

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
OTC Pet Medicine Market - Global Industry Analysis, Forecast for 2032

OTC Pet Medicine Market - Global Industry Analysis, Forecast for 2032

It is predicted to reach 9.95 billion US dollars in 2025 and grow to 13.27 billion US dollars by 2032.

Fairfield Market Research is a research company that publishes highly relevant market data and insightful detailed reports. The global OTC pet pharmaceuticals market is experiencing significant growth, driven by an increase in pet ownership and substantial advancements in pet healthcare products. Fueled by the rising importance of pet health and wellness, the market is expected to grow at a compound annual growth rate (CAGR) of 4.20% throughout the forecast period. The market size is projected to reach USD 9.95 billion by 2025, with further growth anticipated to USD 13.27 billion by 2032. This growth underscores the trend of pets increasingly being regarded as family members and the deepening bond between humans and pets. This report provides a detailed analysis of the OTC pet pharmaceuticals market. It analyzes the market by product type, pet type, pharmaceutical form, and sales channel, and also discusses the strategies and challenges of key market players in detail.

  • others
  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

World Market for Genetic Engineering Pharmaceuticals: Monoclonal Antibodies, Recombinant Human Erythropoietin, Recombinant Human Interferon, Recombinant Human Growth ...

This research report (Global Genetic Engineering Drug Market) investigates and analyzes the current status and outlook for the global market of genetic engineering pharmaceuticals over the next five years. It includes information on the overview of the global genetic engineering pharmaceuticals market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the genetic engineering pharmaceuticals market focus on monoclonal antibodies, recombinant human erythropoietin, recombinant human interferon, recombinant human growth hormone, and recombinant human insulin, while the segments by application cover medical, research, industrial, agricultural, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for genetic engineering pharmaceuticals. The report also includes the market share of major companies in genetic engineering pharmaceuticals, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.